None of us knows, but I for one don't expect there to be any significant news. It wouldn't surprise me to see the liars follow their usual game plan of setting up an expectation of news, and then try to take the stock down when their artificial deadline isn't met (because it's not something the company ever promised). We've seen that one so many times before.

Sox posted the increased number of clinical trial sites the other day. To me that is really good news because it means the company is pushing as hard as they can to get the clinical trials finished as soon as possible. Nobody does that if they aren't confident that the results are going to be really good.

Just look at NNVC -- in business for many years longer than IPIX, and yet they don't have a single clinical trial going.